Signature Resources Capital Management’s Pfizer PFE Stock Holding History

Signature Resources Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.98K	Buy	373 +30	+9%	+$785	﹤0.01%	342
2026 Q1	$9.63K	Buy	343 +78	+29%	+$2.08K	﹤0.01%	299
2025 Q4	$6.6K	Buy	265 +78	+42%	+$1.97K	﹤0.01%	335
2025 Q3	$4.76K	Sell	187 -17	-8%	-$420	﹤0.01%	348
2025 Q2	$4.95K	Buy	204 +146	+252%	+$3.4K	﹤0.01%	343
2025 Q1	$1.47K	Hold	58	–	–	﹤0.01%	321
2024 Q4	$1.54K	Sell	58 -180	-76%	-$4.88K	﹤0.01%	314
2024 Q3	$6.89K	Sell	238 -158	-40%	-$4.61K	0.01%	231
2024 Q2	$11.1K	Hold	396	–	–	0.01%	206
2024 Q1	$11.4K	Hold	396	–	–	0.01%	189
2023 Q4	$11.4K	Buy	+396	New	+$12K	0.01%	191

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Signature Resources Capital Management's PFE Position: Q2 2026 in Review

Signature Resources Capital Management increased its Pfizer (PFE) stake by 8.7% in Q2 2026, buying an estimated $785 and bringing the position to 373 shares worth $8.98K. The position accounts for ﹤0.01% of the portfolio, ranked #342.

Signature Resources Capital Management first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $11.4K in Q1 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Signature Resources Capital Management held 373 shares of Pfizer worth $8.98K as of Q2 2026.
Signature Resources Capital Management bought 30 Pfizer shares in Q2 2026, an estimated $785.
Pfizer made up ﹤0.01% of Signature Resources Capital Management's portfolio in Q2 2026, its #342 holding.
Signature Resources Capital Management first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
Signature Resources Capital Management's Pfizer position peaked at $11.4K in Q1 2024.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Signature Resources Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.